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Abstract: Hepatitis C virus (HCY) infection is
associated with a variety of extrahepatic disorders.
including cryoglobulinaernia and glomerulo-
nephritis. Hepatitis C virus (HCY) glornerulopathy
may be present as a primary glomerular disease.
Our study included 50 adult Egyptian patients who
were diagnosed as idiopathic nephrotic syndrome
(NS). We described the clinical, pathological and
immunological features of these patients. There was
a high prevalence (509<:) of HCY infection among
these patients. The studied risk factors included
history of; blood transfusion (16%) operation (24o/c)
or antibilharzial drugs (76%). Hepatomegaly was
observed in 24% of cases.
Mernbranoproliferative glomerulonephritis (MPGN)
was the commonest pathological type associated with
HCY (48%). Other patterns i ncluded focal segmental
glomerulosclerosis (FSGS) in 32o/t-. membranous in
8% and minimal change glomerulonephritis in 12o/t-.
Cryoglobulins were detected in 5.6% of 18 patients
with HCY and idiopathic NS.
Pateints having HCY infection and membrario-
proliferative glomerulonephritis had hypocomplc-
mentemia and antinuclear antibodies were detected in
41.6%.
Realising that HCY infection may be linked to
different glomerulopathies, thus routine screening for
HCY should be considered in serologic work-up of
patients with glomerulopathy. Nevertheless,
scroepiderniological studies including larger number
of patients with glornerulopathy are therefore
necessary to specify its relation with HCY infection.
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Introd netion
Hepatitis C virus (HCY) is an RNA virus, identified
in 1989 III causing both acute and chronic liver
disease 121. Chronic hepatitis C virus infection i-,
associated with several extrahepatic syndromes.
including mixed cryoglobulinaemia, polyartcriu-,
nodosa, sicca like syndrome 13-61 and
immunologically mediated renal diseases 171.
Several studies have been reported linking HCY and
the occurrence of chronic glomerular diseases
especially mernbranoprolifcrativc glomerulonephritis
(MPGN) 18-101. Studies in the USA, Italy and Japan
suggest that HCY may be an important cause of
cryoglobulinaernic and idiopathic MPGN 1101. It is
likely that HCY is also an important cause of
glomerulonephritis in other areas of the world, but
this had been unrecognized. This is due to the fact
that these patients often lack clinical evidence or
liver disease, and present clinically as a primary
renal syndrome 18,91with minimally elevated trans-
arninases and a remote history or exposure to IICY.
We have no available data in Egypt regarding this
link. Thus the objective or this study was to detect
the prevalence of' IICY among Egyptian patients who
were previously diagnosed as idiopathic nephrotic
syndrome (NS) and to study il' it has a possible
etiologic role in such patients.
Materials and methods
This study included fifty patients (unending the
outpatient clinic or Urology and Nephrology center
of Mansoura University) they were diagnosed as
idiopathic nephrotic syndrome, 32 males and 18
females, their age ranged from 16 to SO years. IICY
infection was diagnosed in all patients by testing for
the presence of HCY antibodies using (ORTIIO-
HCY, Ortho Diagnostic system) and HCY-RNA
(polymerase chain reaction).
According to this result patients were divided into
two groups:
Group I (50%) was positive and group II (50%) was
negative for HCY antigens and antibodies. All
patients were investigated for liver function tests,
serum creatinine, urinary proteinI24h., serum
complement, abdominal ultrasonography and renal
biopsy.
Those twenty five patients with HCY infection were
investigated rol' antinuclear antibodies and
cryoglobulins and then categorised according to the
pathological findings of renal biopsy into 2 groups.
one with mernbranoprolifcrative glomerulonephritis
and the other with other pathological types.
Results
The clinicopathological and laboratory features of
the studied patients are shown in tables (1-8).
Analysis qt the results
Table I. shows that males constituted 689(- of
patients with HCY infection compared to 60,* of
patients without. Females constituted 321'k and 409(-
respectively with a statistically insignificant
difference (P>0.05).
Table 2. shows that the mean age of patients in HCY
group was 35.96 ± 8.36 years while it was 29.60 ±
7.31 years in group Il with a statistically insignificant
difference (P> 0.(5).
Table 3. shows that history of blood transfusion was
present in 16% of group I while it was l2(!c in group
II with statistical insignificant difference (P>O.05).
IIistory of operation was present in 24(!c of group I
patients while il was 12('h in group Il with statistical
insignificant difference (P>0.05). History of
antibilharzial drugs was present in 76('k of HCY
posiuvc group while it was 48(i( alllong IlCY
negative group with statistical significant difference
(P< ().()S).
Hepatomegaly was present in 241.* of the patients in
IlCY positive group while it was found in only 4(i(,
in the patients of llCY negative group with statistical
significant difference (P<0.05).
Table 4. shows that the serum bilirubin was 0.66 ±
0.46 nig/dl in group Il cases while it was 0.53 ± 0.20
rug/dl among IICY negative group with statistical
insignificant difference (P> 0.(5).
The mean level of SGPT was 35.76 ± 29.53 lUlL in
group I while it was 19.8 + 13.5 lUlL in group Il
with statistical significant difference (P< 0.05).
The mean level of SGOT was 43.32 ± 29.89 lUlL
and 22.48 ± 6.01 lUlL in groupl&lIrespectivly
with statistical significant difference (P< 0.(5).
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The mean level of serum albumin was 2.48 ± 0.59
gldl and 2.32 ± 0.67 gldl in group I & II respectivly
with statistical insignificant difference CP>0.05).
The mean value of cholesterol levels were 378.8
±85.8 mg/dl and 350.0 ± 67.8 mg/dl in group I & II
respectivly with statistical insignificant difference
(P>0.05).
The mean value of 24 hours urinary protein was
3.77± 2.26 gm in group Iwhile it was 3.68 ± 3.11
gm in group IIwith statistical insignificant difference
(P>0.05).
The mean level of serum creatinine was 0.92 ± 0.22
rug/dl and 0.88 ± 0.28 md/dl in group I & II
respectivly with statistical insignificant difference
(P>0.05).
The pathological findings of the renal biopsy as
shown In table 5 include, focal segmental
glomerulosclerosis in 32%, membranoproliferative in
48%, membranous in 8% and minimal change in
12% among patients in group I while it was focal
segmental glomerulosclerosis in 60%, rnernbrano-
proliferative glomerulonephritis in 8%, membranous
glomerulonephritis in 4%, minimal change
glomerulonephritis In 12% and rnesangial
proliferation in 16% of group IIcases. A statistical
significant difference between both groups was
present in FSGS, MPGN and rnesangial proliferation
(P<0.05).
Table 6. shows that the mean value of complement
three (C3) was 92.59±40.47 rug/dl among HCY
positive patients with MPGN group while it was
141.49±33.96 rug/dl among the same group with
other pathological types with statistical significant
difference (P<0.05).
The mean value of complement four (C4) was
22.72± 14.81 rug/dl in HCY positive patients with
MPGN while it was 45.5l±14.20 mg/dl among
patients in the same group with other pathological
types with statistical significant difference (P<0.05).
Table 7. shows that the antinuclear antibodies were
strongly positive in 8.3% but weak positive in 33.3%
or HCY positive patients with MPGN compared to
23.1 (i( and 7.79(- respectively among patients in the
positive group with other pathological types with a
statistical significant difference (P>0.05).
Table 8. shows that croyoglobulins were detected in
9.1 (k among I I patients with HCY associated
MPGN compared to 0% among 7 patients with Hey
and with other pathological types but this
comparison is not statistically valid as one group
contains only one subject.
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5 No % No %
Males 17 68.0 15 60.0
Females 8 32.0 10 40.0










Table 2. Means ± S.D. of age among the studied patients according to HCV infection































4 16.0 3 12.0 7 14.0 0.408 >0.05·
6 24.0 3 12.0 9 18.0 1.104 >0.05·
19 76.0 12 48.0 31 62.0 2.()40 <0.05·*
6 24.0 I 4.0 7 14.0 2.038 <0.05*·
*·Signifïcant* Non-vignificaru
Table 4. Liver function test-, and parameter, of nephrotic syndrome among our patient, according to HeV infection
~V
HeV po,itivc /lCV »cgativc
L x + S.D. x +S.D .
.5. bilirubin 0.66 ± 0.46 OSl± 0.20 1.259
.SGPT 35.76 ± 26.53 19.H± 13.5 2.457
.SGOT 43.32 ± 29.89 22.48 ± 6.01 3.417
.5. Albumin 2.48 ± 0.59 2.32 ±0.67 0.924
.5. cholesterol 378.8 ± 85.8 350.0 ± 67.8 1.311
.5. creatinine 0.92 ± 0.22 0.88 ± 0.28 0.553
.u. protein/24h 3.77 ± 2.26 3.68 ± 3.11 0.109









Table 5. Renal histopathology in both HCY positive and negative groups
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z pHey Hey positive Hey negative
Pathology No % No %
FSGS 8 32.0 IS 60.0
MPGN 12 48.0 2 8.0
Membraous 2 8.0 I 4.0
Minimal change 3 12.0 3 12.0
Mesangial prolil 0.00 0.00 4 16.0
Total 25 100.0 25 100.0


































A No '7< No % No %
Weak 4 33.3 3 23.1 7 28.0
Strong 8.3 7.7 2 8.0
















Cryoglobulins No % %No % No
Cryoglobulin, 9.1
Discussion
Hepatitis C virus (HCY) is an RNA virus, identified
in 1989 II]. It causes both acute and chronic liver
disease and is a major cause of both transfusion
associated and sporadic non-A non-B hepatitis.
Persistent infection occurs in approximately 50% of
patients, it is often clinically silent and may result in
chronic active hepatitis, cirrhosis and possibly
o 0.0 5.56
hepatocellular carcinoma [Z]. Chronic hepatitis C
virus infection, when presist for over ten years and
especially in preseenee of chronic active hepatitis or
cirrhosis, is associated with several extrahepatic
syndromes, including mixed cryoglobulinaemia,
polyarteritis nodosa and sicca like syndrome [3-6].
HCY infection may be associated with
immunologically mediated renal diseases [7].
Several studies reported the link between HCY and
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chronic glomerular diseases especially membrano-
proliferative glomerulonephritis [8-10). However we
have no available data in Egypt regarding this link.
In this study, we reported an association of Hey
infection with idiopathic NS in 50% of the studied
patients. Similarly, many reports confirmed this
association [7,9,11). The high percentage of anti-
Hey seropositivity suggests that this virus may play
an important role in the pathogenesis of this
immune-mediated glomerulonephritis. One the other
hand, other reports did not find such association
[12,14]. This difference may be related to the
endemicity of Hey in Egypt as its prevalence ranged
from 10-20% among the general population [15].
Other factors considered may include specific
genotype associated with particular complication as
glomerulonephritis and the duration of infection
[16J. Exposure to risk factors was present in 40% of
Hey positive patients including blood transfusion
( 16%) or operations (24%) (table 3). Other reports
showed different results (16,9). This may be related
to different prevalence and endemicity of Hey
among di fferent population [17], different genotypes
[18] and different habits [19]. The majority (76%) of
our Hey positive patients received one or more
courses of antibilharzial drugs (table 3). This may be
related to the endemicity of schistosomiasis in Egypt
[19]. The relationship between Hey and
glomerulopathy in the presence or absence of
schistosomiasis should be speciefied as different
relations were reported [16,20].
ft is of interest that the presence of hepatomegally
among the patients with Hey (24%) was
significantly higher than those without Hey (4%)
(table 3). The mean values of SGPT and SGOT
among patients with Hey were significantly higher
than those without Hey (table 4) this is in a
greement with other reports [7,9]. However, the
lower values of transaminase may be related to the
effect of the administrated corticosteroid [21],
different genotypes and the absence of HBY
infection [19].
In this study, membranoproliferative glomerulo-
nephritis was the commonest (48%) pathological
pattern among patients with Hey (tableS) and this is
similar to many reports [9,11,16).
Our patients with Hey and membranoproliferative
glomerulonephritis showed lower level of
complement 3 and complement 4 than those with
Hey and other pathological types (table 6). MPGN
is known to be associated with hypocomplementemia
and is sometimes called hypocomplementemic
glomerulonephritis [22]. The presence of antinuclear
antibodies (ANA) was detected in 36% among
patients with Hey (table 7) which could be related
to the association between chronic Hey infection
and development of autoantibodies [23].
Cryoglobulins were detected in one out of eighteen
~ patients, with Hey and idiopathic NS (table 8).
Different reports showed different results [9,16,24J.
This difference may be related to several factors
including; the duration and severity of chronic liver
disease [25], different geographical areas [24], the
administrated immunosuppressive drugs [26,27] and
previous HBY infection [7,28]. Follow up of
cryoglobulins is recormmended as it may develope
later [9].
We may conclude that there was a high prevalence of
Hey infection among patients with idiopathic NS.
Those with MPGN, hepaiomegally, elevated
transaminases and history of antibilharzial drugs are
at increased risk. MPGN was the commonest
pathological type associated with Hey.
Accepting that Hey infection may be linked to
several glomerulopathies, routine screening of these
patients for Hey should be considered in their
serologic work-up. Nevertheless, seroepidemiolo-
gical studies including larger number of patients with
glomeulopathy are necessary to specify its relation
with I:-lCY infection.
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